Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
[Translated article] Use of Anifrolumab in Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus, and Other Autoimmune Dermatoses.
Actas Dermosifiliogr
January 2025
Servicio de Dermatología, Hospital de Figueres, Fundació Salut Empordà, Girona, Spain; Servicio de Dermatología, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. Electronic address:
Article Synopsis
- Anifrolumab is a drug that blocks a specific receptor (IFNAR1) and is approved for treating moderate-to-severe systemic lupus erythematosus (SLE).
- * In clinical trials, it has shown effectiveness for skin-related lupus issues, even though it's not specifically approved for cutaneous lupus erythematosus (CLE).
- * Ongoing studies aim to assess its effectiveness for different types of lupus and related conditions, while its common side effects include respiratory infections and herpes zoster.
Antihelical erythema/papules as a potential risk factor for acute and subacute interstitial pneumonia in MDA5+ dermatomyositis: A retrospective cohort study.
J Am Acad Dermatol
December 2024
Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Electronic address:
Identification of common mechanisms and biomarkers for dermatomyositis and atherosclerosis based on bioinformatics analysis.
Skin Res Technol
June 2024
Department of cardiovascular, Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi, China.
Background: Dermatomyositis (DM) manifests as an autoimmune and inflammatory condition, clinically characterized by subacute progressive proximal muscle weakness, rashes or both along with extramuscular manifestations. Literature indicates that DM shares common risk factors with atherosclerosis (AS), and they often co-occur, yet the etiology and pathogenesis remain to be fully elucidated. This investigation aims to utilize bioinformatics methods to clarify the crucial genes and pathways that influence the pathophysiology of both DM and AS.
View Article and Find Full Text PDFA rare case report of bilateral Purtscher-like retinopathy in juvenile dermatomyositis.
GMS Ophthalmol Cases
May 2024
Department of Pathology, Christian Medical College, Vellore, India.
Purpose: To report a rare case of bilateral Purtscher-like retinopathy (PLR) in a young adult diagnosed with dermatomyositis.
Method: A case report with multi-modal imaging.
Result: A 17-year-old male presented with subacute marked diminution of vision along with arthralgia, weakness of all four limbs and development of multiple rashes around body.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!